Immunoglobulin on tumor cells and tumor-induced lymphocyte blastogenesis in human acute leukemia

The New England Journal of Medicine
J U GuttermanE M Hersh

Abstract

No abstract listed.

References

Oct 16, 1971·Lancet·M PapamichailE J Holborow
Apr 5, 1969·Lancet·G MathéF De Vassal
Jan 1, 1970·Annual Review of Microbiology·K E Hellström, I Hellström
Nov 1, 1971·The New England Journal of Medicine·E M HershE J Freireich
Jun 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·H O SjögrenK E Hellström
Jan 15, 1967·International Journal of Cancer. Journal International Du Cancer·E KleinC A Hamberger
Feb 27, 1971·British Medical Journal·R L PowlesP Alexander
Mar 27, 1914·Science·H M Evans, W Schulemann

Citations

Jan 1, 1977·Journal of Surgical Oncology·H Handelsman
Sep 1, 1977·World Journal of Surgery·C R Meier, A F LoBuglio
Mar 1, 1992·Indian Journal of Pediatrics·J KishoreM Bhargava
Apr 19, 1973·The New England Journal of Medicine·P L Weiden
Nov 1, 1975·The Journal of Experimental Medicine·G OpelzP I Terasaki
Mar 1, 1976·International Journal of Dermatology·E M HershG Mavligit
Jan 1, 1973·Transplantation Reviews·S S Froland, J B Natvig
Jun 22, 1974·British Medical Journal·D CatovskyD A Galton
Dec 1, 1973·The Journal of Clinical Investigation·K J Gajl-PeczalskaR A Good
Jan 1, 1974·The Journal of Clinical Investigation·A H JohnsonW N Suki
Aug 1, 1974·The Journal of Clinical Investigation·E M HershE J Freireich
Jan 1, 1976·Annals of the New York Academy of Sciences·J P CotropiaG Mavligit
Jun 1, 1978·Clinics in Haematology·T Mohanakumar, R B Raney
Aug 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P GmürP W Straub
Jul 1, 1976·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W F Piessens, W C Moloney
Jan 1, 1975·Medical and Pediatric Oncology·R R Ellison
Jan 1, 1976·Clinical Immunology and Immunopathology·I SchedelH Deicher
Mar 1, 1974·Cancer Treatment Reviews·E M HershG Mavligit
Mar 1, 1975·Cancer·B Leventhal
Oct 1, 1974·Cancer·D L MannB Leventhal
Jul 1, 1978·Cancer·J O Moore, G L Logue
May 1, 1975·Cancer·G B HumphreyM E Nesbit
May 11, 1976·Cancer·C A SchifferJ M Joseph
Jan 1, 1974·Annals of the New York Academy of Sciences·J B Block
Jan 1, 1976·CRC Critical Reviews in Clinical Laboratory Sciences·G W Warr, J J Marchalonis
Oct 15, 1977·International Journal of Cancer. Journal International Du Cancer·J P CotropiaG Mavligit
Jan 1, 1979·Medical and Pediatric Oncology·J Zusman, M E Nesbit
Dec 15, 1977·International Journal of Cancer. Journal International Du Cancer·R Fäldt, J Ankerst
May 1, 1973·International Journal of Cancer. Journal International Du Cancer·J U GuttermanE M Hersh
Nov 1, 1973·Postgraduate Medicine·S E JonesS E Salmon
Sep 15, 1974·International Journal of Cancer. Journal International Du Cancer·U AmbusE M Hersh
Nov 1, 1976·Tissue Antigens·B SchacterR L Humphrey
Sep 1, 1980·Scandinavian Journal of Haematology·A HarlozinskaR Richter
Sep 15, 1973·International Journal of Cancer. Journal International Du Cancer·D H CharR B Herberman

Related Concepts

Antibody Formation
Immune complex
Tumor Antigens
Plasma Membrane
Immunofluorescence Assay
IgA2
Polyglobin
IgM2
Immune Sera
Cellular Immune Response

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.